HOME › DRUGS › CEMIPLIMAB
ACTIVE SUBSTANCE / INN

CEMIPLIMAB

Brand name(s): Libtayo
EMA LISTED
AUTHORISED
Carcinoma, Squamous Cell
ACTIVE SUBSTANCE
Cemiplimab
REGULATORS
EMA
SPONSORS / MAH
Regeneron Ireland Designated Activity Company (DAC)
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
LibtayoRegeneron Ireland Designated Activity Company (DAC)Authorised28/06/2019Carcinoma, Squamous Cell

FULL INTELLIGENCE ON CEMIPLIMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →